Evolution of the Average Target: Neurizon Therapeutics Limited

Evolution of the Target Price: Neurizon Therapeutics Limited

Changes in Analyst Recommendations: Neurizon Therapeutics Limited

1949e2a635c6ac0823ea1c33.157jUPrrTob1DD9UhL-a0mXtDrgZBmJIw0AbjT_fLoQ.gse8ObesH7OlTX4ez9jCnR2aPv9IbVEQhgJq_xK-Zby-_5cPtpsE0I87TA~91108ba88f61d2767b9091de02354cac

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +201.08%
+12.1%
-3.64%
+9.8%
-1.43%
-0.54%
+9.11%
-5.26%
-11.03%
+30.61%
Average +24.08%
Weighted average by Cap. +4.94%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0930AUD
Average target price
0.2800AUD
Spread / Average Target
+201.08%
High Price Target
0.2800AUD
Spread / Highest target
+201.08%
Low Price Target
0.2800AUD
Spread / Lowest Target
+201.08%

Analyst Consensus Detail

Consensus revision (last 18 months)

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0930AUD
Average target price
0.2800AUD
Spread / Average Target
+201.08%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NUZ Stock
  4. Consensus Neurizon Therapeutics Limited